95 related articles for article (PubMed ID: 3907845)
1. Respiratory infections: clinical evaluation.
Grassi C
Clin Ther; 1985; 7 Suppl A():45-54. PubMed ID: 3907845
[TBL] [Abstract][Full Text] [Related]
2. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
Møller NE; Høiby N
Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
6. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
[TBL] [Abstract][Full Text] [Related]
7. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
Nichols L; Maki DG
Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
[TBL] [Abstract][Full Text] [Related]
8. [Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].
Lanni N; Scaglione B
Minerva Med; 1986 Mar; 77(9-10):317-9. PubMed ID: 3485265
[TBL] [Abstract][Full Text] [Related]
9. Tobramycin and carbenicillin compared with gentamicin and carbenicillin in the treatment of infection with Pseudomonas aeruginosa in adult patients with cystic fibrosis.
Hodson ME; Wingfield HJ; Batten JC
Br J Dis Chest; 1983 Jan; 77(1):71-7. PubMed ID: 6407508
[TBL] [Abstract][Full Text] [Related]
10. Comparison of piperacillin alone versus piperacillin plus tobramycin for treatment of respiratory infections in children with cystic fibrosis.
McCarty JM; Tilden SJ; Black P; Craft JC; Blumer J; Waring W; Halsey NA
Pediatr Pulmonol; 1988; 4(4):201-4. PubMed ID: 3393383
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
Hou F; Li J; Gao L; Chen Y
Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of piperacillin in the urological field].
Hayashida S; Kitajima K; Joko K
Hinyokika Kiyo; 1983 Apr; 29(4):465-76. PubMed ID: 6563846
[TBL] [Abstract][Full Text] [Related]
13. Adverse reactions to piperacillin in adults with cystic fibrosis.
Stead RJ; Kennedy HG; Hodson ME; Batten JC
Thorax; 1985 Mar; 40(3):184-6. PubMed ID: 3983886
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
Covi M; Velluti G
J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
[TBL] [Abstract][Full Text] [Related]
15. Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
Sweet RL; Roy S; Faro S; O'Brien WF; Sanfilippo JS; Seidlin M
Obstet Gynecol; 1994 Feb; 83(2):280-6. PubMed ID: 8290195
[TBL] [Abstract][Full Text] [Related]
16. Piperacillin and gentamicin v carbenicillin and gentamicin for treatment of serious gram-negative infections.
Kohler RB; Foerster LA; Wheat LJ; Williams JM; Reynolds J; Norton J
Arch Intern Med; 1982 Jul; 142(7):1335-7. PubMed ID: 6212035
[TBL] [Abstract][Full Text] [Related]
17. Piperacillin and tobramycin in the treatment of Pseudomonas lung infections in cystic fibrosis.
Hoogkamp-Korstanje JA; van der Laag J
J Antimicrob Chemother; 1983 Aug; 12(2):175-83. PubMed ID: 6619055
[TBL] [Abstract][Full Text] [Related]
18. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
[TBL] [Abstract][Full Text] [Related]
20. Azlocillin in cystic fibrosis.
Malmborg AS; Alfredsson H; Strandvik B
Isr J Med Sci; 1983 Nov; 19(11):1001-3. PubMed ID: 6662681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
